Purpose: The purpose of this study was to report the mid-term survival results of Oxford UKAs in patients of 50 years of age or less, using (1) revision surgery and (2) Oxford Knee Scores (OKS) as outcome measures.

Method: A literature review identified studies of Oxford mobile bearing UKAs containing individuals 1) 50 years old or less with 2) medial osteoarthritis and 3) 2 years or longer follow-up. Authors were approached to participate in a multi-centre survival analysis by submitting all their patients, 50 years of age or less, who received a medial UKA for osteoarthritis. Patients who had died, been lost to follow-up or who underwent revision were identified. OKS were established for all patients with surviving implants.

Results: Seven centres submitted 107 patients. The mean age was 47 years (range 32–50). The average follow-up was 4 years (range 1–25). Forty-seven patients had follow-up into their fifth year or longer. The cumulative 7-year survival using revision as the endpoint was 96% (CI 8). The mean post-operative OKS for surviving implants was 38 (CI 2) out of a possible 48.

Conclusion: While early survival rates and function are encouraging, long-term follow-up is required before concluding UKA is a viable treatment option in young patients with unicompartmental knee arthritis.

Aim: This paper presents the 20-year survival and 10-year clinical follow-up results from the entire series of all medial Oxford meniscal bearing unicompartmental knee arthroplasties performed in a single centre in Sweden, between 1985 and 2004.

Method: Patients were contacted and information about the state of the knee collected. Revision surgery was used in the life-table survival analysis performed. For the entire cohort clinical follow up at 10-years is routinely performed, using the HSS knee score.

Results: The entire group comprised of 683 knees in 572 patients. The mean age at implantation was 69.7 (range 48–94). There had been 30 revision procedures: 8 for lateral arthrosis, 7 for component loosening, 3 for infection, 6 for bearing dislocation, 1 for bearing fracture and 5 for unexplained pain. The 10-year, 15-year and 20-year survival (all cause revision) were 94.1 % (CI 2.9, 237 at risk), 93.5% (CI 4.6, 101 at risk) and 92.3% (CI 15.1, 11 at risk) respectively. From the patients reviewed clinically the mean pre-operative HSS knee score was 57 (95% CI 1), compared to 87 (95% CI 1) at 10-years. Using HSS criteria the results were: 68% excellent, 23% good, 6% moderate and 2% poor.

Conclusion: The results show that this mobile bearing unicompartmental prosthesis offers patients excellent clinical results during the first decade and is durable during the second decade after implantation.

The purpose of this study was to establish the long-term clinical outcome of the Oxford Medial Unicompartmental Knee Arthroplasty (UKA).

Methods: A continuous series of 420 patients underwent medial Oxford UKA. Indications were anteromedial osteoarthritis with full thickness lateral compartment cartilage, a functioning anterior cruciate ligament and correctable varus deformity. Survival analysis with all cause revision as the endpoint was carried out for the entire group. At the time of this study 121 were still alive at 10 years and pre/post-operative 10-year clinical data had been prospectively recorded for them from which the AKS and HSS scores were calculated. Results: Seventeen patients required revision (4%) and the fifteen year survival rate was 94.3% (95% CI 85.6 - 100%). At ten years AKS and HSS scores were: AKSS (Knee) pre 30 / post 90, AKSS (Function): pre 42/ post 69 and HSS pre 56/ post 86. The differences were statistically significant (p< 0.01).

Discussion and Conclusion: We conclude that providing careful patient selection is maintained, meniscal bearing medial unicompartmental knee arthroplasty has clinical and survival results comparable to modern total knee arthroplasty. The advantages of lower morbidity and earlier return to function, enhanced by the introduction of minimally invasive techniques may make this the treatment of choice for suitable patients with anteromedial osteoarthritis of the knee.

To report a 15-year survival analysis of the Oxford Medial Unicompartmental Knee Arthroplasty (Oxford UKA) in an independent series.

We report the results of a series of 420 Oxford UKAs performed between 1983 and 2000. Indications for surgery were primary antero-medial osteoarthritis of the knee with an intact ACL, correctable varus deformity of < 15° and < 15° fixed flexion deformity. The state of the patello-femoral joint was not used as a selection criterion. Patients were contacted by a postal questionnaire or by telephone. The outcome of all 420 knees was established, with none lost to follow-up. Seventy-six knees were in patients who had died and the state of each arthroplasty was determined from hospital and GP records.

Seventeen patients (4%) had required revision. Indications for revision were lateral compartment arthrosis (7), component loosening (4), bearing dislocation (4) and infection (2). There were no failures for polyethylene wear. Cumulative survival at 15 years was 94.3% [95% CI 3.8%]. The worst case scenario was 94.3% as none were lost to follow-up.

The results from an independent series are important, as they avoid bias. The 15-year results of this independent series are better than any other reported series of unicompartmental device at 15 years and as good as the published independent 15 year survival results for total knee arthroplasty. The data illustrates that excellent long-term survival can be achieved with the Oxford UKA, allowing patients to benefit from the advantages that unicompartmental arthroplasty offers. We believe that provided patients are selected appropriately, this device provides the treatment of choice for anteromedial osteoarthritis of the knee.